Literature DB >> 1808130

Safety and tolerability of iodixanol. A dimeric, nonionic contrast medium: an emphasis on European clinical phases I and II.

B Bolstad1, K W Borch, B H Grynne, B Lundby, J O Nossen, Y F Kloster, D T Kristoffersen, E Andrew.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1808130     DOI： 10.1097/00004424-199111001-00069

Source DB:  PubMed          Journal:  Invest Radiol        ISSN： 0020-9996            Impact factor:   6.016


× No keyword cloud information.
  5 in total

1.  Iodixanol as a density gradient medium for the isolation of motile spermatozoa.

Authors:  K Harrison
Journal:  J Assist Reprod Genet       Date:  1997-08       Impact factor: 3.412

2.  Iodixanol in intra-arterial cerebral digital subtraction angiography: a comparison with iohexol.

Authors:  B E Kendall; A Sheppick; J O Nossen; J M Stevens
Journal:  Neuroradiology       Date:  1995-10       Impact factor: 2.804

3.  Iodixanol vs iopamidol in intravenous DSA of the abdominal aorta and lower extremity arteries: a comparative phase-III trial.

Authors:  R Fischbach; P Landwehr; K Lackner; J O Nossen; W Heindel; K J Berg; G Eichhorn; T F Jacobsen
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

4.  Contrast-induced nephropathy: pharmacology, pathophysiology and prevention.

Authors:  Remy W F Geenen; Hylke Jan Kingma; Aart J van der Molen
Journal:  Insights Imaging       Date:  2013-10-03

5.  Improving Single-Cell Encapsulation Efficiency and Reliability through Neutral Buoyancy of Suspension.

Authors:  Hangrui Liu; Ming Li; Yan Wang; Jim Piper; Lianmei Jiang
Journal:  Micromachines (Basel)       Date:  2020-01-15       Impact factor: 2.891
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.